Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial. (Q51001453)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 May 2013

Language	Label	Description	Also known as
English	Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.	scientific article published on 10 May 2013

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

phase I clinical trial

0 references

phase II clinical trial

0 references

0 references

Herwig Kollaritsch

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Benjamin J. Luft

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Markus Alexander Zeitlinger

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

6

object named as

Sandor Fritsch

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Hartmut J Ehrlich

23

object named as

Hartmut J Ehrlich

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

24

object named as

P Noel Barrett

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Peter Gottfried Kremsner

22

object named as

Peter G Kremsner

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Nina Wressnigg

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Eva-Maria Pöllabauer

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Gerald Aichinger

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Daniel Portsmouth

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Alexandra Löw-Baselli

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Ian Livey

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Brian A Crowe

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Michael Schwendinger

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Peter Brühl

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Andreas Pilz

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Thomas Dvorak

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Julia Singer

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Bernhard Schmitt

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Markus Müller

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Maria Paulke-Korinek

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Meral Esen

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

10 May 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Lancet Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

680-689

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lyme borreliosis: clinical case definitions for diagnosis and management in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Correcting a public health fiasco: The need for a new vaccine against Lyme disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Differentiation of reinfection from relapse in recurrent Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccines against Lyme disease: What happened and what lessons can we learn?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Approaches toward the directed design of a vaccine against Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A new approach to a Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

If nothing goes wrong, is everything all right? Interpreting zero numerators

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

An open-label, nonrandomized, single-center, prospective extension, clinical trial of booster dose schedules to assess the safety profile and immunogenicity of recombinant outer-surface protein A (OspA) Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and immunological assessment of a candidate Lyme disease vaccine in healthy adults: antibody persistence and effect of a booster dose at month 12

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternative vaccination schedules (0, 1, and 6 months versus 0, 1, and 12 months) for a recombinant OspA Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Aluminium adjuvants--in retrospect and prospect

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of stimulation of the immune response by aluminum adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and Immunogenicity of an Outer Surface Protein A Vaccine in Subjects with Previous Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlates of protection induced by vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970110-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(13)70110-5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

release_xcmajcro6vf3nbvjvmpyvbdaja

1 reference

https://api.fatcat.wiki/v0/release/xcmajcro6vf3nbvjvmpyvbdaja

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23665341%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51001453&oldid=1843763605"